Investigational Site Number: 8400005

Nashville, Tennessee 37203

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer, Plasma Cell Myeloma, Prostate Cancer

Studies at this site

• A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
• Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies — Stopped early